HEINRICH-HEINE-UNIVERSITAET DUESSELDORF
The Institute of Molecular Enzyme Technology (IMET) (headed by Prof. Karl-Erich Jaeger) is a part of the Heinrich-Heine-University of Düsseldorf (UDUS) located on campus of the Research Centre Juelich, Europe’s largest research facility. IMET is part of the Institute of Bio- and Geosciences-IBG-1 which holds a leading position nationally and internationally in the field of basic research and biotechnological applications of microorganisms. Work at IMET covers the scientific topics «microbial cell factories», «metagenomics», “natural product biosynthesis”, «photobiotechnology», and «molecular biophotonics».
WP1: Representing the project management and coordination activities.
WP2: Implementing machine learning platform to screen enzymes demanded by manufacturers.
WP3: Implementing activity-based platforms to screen enzymes demanded by manufacturers.
WP4: Implementing systems for producing and characterising enzymes and finding best ones.
WP5: Improving the performance of the best enzymes through novel engineering techniques.
WP8: Focusing on dissemination, exploitation and communication.
Dr. Karl-Erich Jaeger
is a professor of Molecular Microbiology at the Heinrich-Heine-University of Düsseldorf and Director of the Institute of Molecular Enzyme Technology at the Research Centre Juelich. He is an editorial board member of various scientific journals and vice-president of the German Cluster for Industrial Biotechnology (CLIB), a consortium of currently 100 members from universities, research institutions, large and medium-sized Biotech companies. His scientific activities focus on enzymes from bacteria, their identification by metagenomics, expression, purification, and optimization by directed evolution.
Dr. Fabienne Hilgers
Dr. Fabienne Hilgers has studied biochemistry at the Heinrich Heine University Düsseldorf and in December 2021, she completed her PhD thesis focusing on the use of light as a stimulus for controlling diverse microbial processes such as gene expression, cell viability or the production of versatile natural products. The thesis was conducted in the framework of the Bioeconomy Science Center (BioSC) FocusLab ‘CombiCom’.
Former members
Dr. Alexander Bollinger
has studied biology at Heinrich-Heine-University and just complete (August 2020) his PhD thesis on the exploitation of novel robust lipolytic enzymes with industrial applicability in 2020. He pursued his thesis work in close cooperation with partners of the INMARE project.